Raymond James Financial’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$977K Buy
209,146
+28,830
+16% +$135K ﹤0.01% 3597
2025
Q1
$990K Buy
180,316
+167,166
+1,271% +$918K ﹤0.01% 3489
2024
Q4
$44.6K Buy
+13,150
New +$44.6K ﹤0.01% 4571